ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
£¨1£©Ñª½¬ÂѰ×Á¬ÏµÊÔÑ飨PPB£©£ºÆ¾Ö¤ 2014 °æ¡¶ÁÙ´²Ç°Ò©´ú¶¯Á¦Ñ§Ñо¿Ö¸µ¼ÔÔò¡·£¬ÊÔÑéÐèÉè¼Æ N=3£¬²¢¹Ø×¢Å¨¶ÈÒÀÀµÐÔºÍÖÖÊô²î±ð£»
£¨2£©ÌåÍâ´úлÑо¿£¨Metabolic Stability/MetID£©£ºÖØµã¹Ø×¢ÖÖÊô²î±ð£¬ÎªÌåÄÚ PK Ñо¿¡¢¶¾ÀíѧÆÀ¼Û¼°ÖÖÊôÑ¡ÔñÌṩ²Î¿¼£»
£¨3£©ÌåÍâÒ©ÎïÏ໥×÷Óã¨DDI£©Ñо¿£º°üÀ¨ P450 ÒÖÖÆÓëÓÕµ¼£¨Êý¾ÝÆÊÎö¿É²Î¿¼ FDA Ö¸ÄÏ£ºDDI 2006 Draft ºÍ 2020 In Vitro DDI£©£¬ÒÔ¼°Ã¸±íÐÍ£¨CYP/Non-CYP ´úл;¾¶£©Åжϣ»
£¨4£©×ªÔËÌåÑо¿£¨Transporter Substrate Assessment & Inhibition£©£ºÖ÷ҪתÔËÌå°üÀ¨ Caco-2¡¢P-gp¡¢BCRP¡¢OATP1B1¡¢OATP1B3¡¢OAT1¡¢OAT3 ºÍ OCT2¡£